Physician's First Watch Archive

Medical news from NEJM Journal Watch

July 7, 2015

By Kelly Young

Edited by David G. Fairchild, MD, MPH

Patients may ask about a new study showing that more mammography screening is associated with a higher rate of breast cancer diagnosis — but not reduced breast cancer mortality. The findings appear in JAMA …

By Jenni Whalen

Edited by David G. Fairchild, MD, MPH

The majority of healthcare providers work while they're sick, a JAMA Pediatrics study finds.

Over 500 clinicians from a Philadelphia children's hospital completed an anonymous survey about …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH

The extent of coronary artery calcification (CAC) among asymptomatic patients can accurately predict mortality through 15 years of follow-up, according to a single-center, observational study in the Annals of Internal Medicine. …

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: Clinical Problem-Solving: A 67-year-old man with hairy-cell leukemia …

July 6, 2015

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Cystic fibrosis received much attention late last week: a nonviral gene therapy conferred significant (although modest) benefits to lung function in an early trial, and the FDA approved a new combination drug therapy for the condition.

In the …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

A front-page story in Sunday's New York Times casts a harsh light on the growing diet-clinic industry in the U.S.

The Affordable Care Act requires insurers to pay for obesity screening and, …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Many U.S. health insurance companies are seeking large rate increases for 2016 because the customers they've gained under the Affordable Care Act are "sicker …

July 2, 2015

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

The FDA is mandating that drug companies stop manufacturing unapproved otic drops that are labeled for prescription use to relieve ear pain, infection, and inflammation. These products are frequently …

By Allan S. Brett, MD

Dr. Brett is editor-in-chief of NEJM Journal Watch General Medicine, from which this story was adapted. See full coverage at the link below.

Liraglutide helps nondiabetic patients lose weight, but gastrointestinal side effects are common, according to an industry-supported study in the New …

Pages